Jill Fulcher

4PUBLICATIONS
19CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 31, 2025
Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL.

Daniela R Anderson, Radhika Gangaraju, Wafik George Sedhom

|Apr 25, 2025
Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective.

Tana Saiyin, Grace Christou, Mitchell Sabloff

|Mar 22, 2021
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.

Jill Fulcher, Philip Berardi, Grace Christou

|May 20, 2020
Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia.

Jill Fulcher, Eugene Leung, Grace Christou

Pageof 1

Frequent Collaborators

3 joint publications

Mitchell Sabloff

1 joint publications

Tina Crosbie

1 joint publications

Eva N Hamulyák

1 joint publications

Tzu-Fei Wang